-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-1103 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-1103 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DS-1103 in Non-Small Cell Lung Cancer Drug Details: DS-1103...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-172154 in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-172154 in Epithelial Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SL-172154 in Epithelial Ovarian Cancer Drug Details:SL-172154 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – SL-172154
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry SL-172154 Drug Details SL-172154 is under development for the treatment of colon cancer, advanced...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TTI-621
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry TTI-621 Drug Details TTI-621 (SIRPa Fc) is under development for treatment of relapsed or...